文献速递肿瘤 PET/CT放射性药物与辐射防护

FDG-PET/CT诊断移植后淋巴增殖性疾病的效能及影响因素

Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2019-08-24

该回顾性研究纳入91例临床怀疑移植后淋巴增殖性疾病(PTLD)的患者共97次FDG-PET/CT检查,以病理和2年随访为参考标准,评估诊断效能并分析影响因素。结果显示灵敏度85%、特异度90%、阳性预测值83%、阴性预测值92%,观察者间一致性良好(k=0.78);仅乳酸脱氢酶(LDH)水平与真阳性结果相关(OR 1.03,p=0.04)。

要点

  • FDG-PET/CT诊断PTLD灵敏度85%、特异度90%、阴性预测值92%,观察者间一致性良好(k=0.78)。
  • 仅LDH水平与真阳性FDG-PET/CT结果相关(OR 1.03,p=0.04)。
  • EBV-DNA载量和移植后FDG-PET/CT时机不影响诊断效能。

核心结论

  • FDG-PET/CT在疑似PTLD患者中具有良好诊断效能和观察者间一致性。
  • 仅LDH水平似乎影响FDG-PET/CT的检测效能,EBV-DNA载量和检查时机无影响。

研究设计与样本

  • 回顾性研究纳入91例临床怀疑PTLD的患者,共97次FDG-PET/CT检查,跨度8年。
  • 以病理报告和2年随访为参考标准,评估诊断效能并行 logistic 回归分析影响因素。

主要发现

  • 灵敏度85%、特异度90%、阳性预测值83%、阴性预测值92%,观察者间一致性k=0.78。
  • 在假设与真阳性结果相关的参数中,仅LDH有统计学意义(OR 1.03,p=0.04)。

关键数值与推荐

  • 灵敏度85%、特异度90%、阳性预测值83%、阴性预测值92%。
  • 观察者间一致性k=0.78。
  • LDH与真阳性FDG-PET/CT结果相关(OR 1.03,p=0.04)。

临床怎么用

  • 对临床怀疑PTLD的患者,FDG-PET/CT可作为诊断评估工具,阴性预测值较高有助于排除诊断。
  • LDH水平升高可能提示FDG-PET/CT更易获得真阳性结果,但EBV-DNA载量和移植后检查时机不应作为选择检查的依据。

局限性

  • 回顾性研究设计。
  • 单中心研究,样本量有限(91例患者、97次检查)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Post-transplant lymphoproliferative disorder (PTLD) is a serious complication after solid organ and hematopoietic stem cell transplantation, requiring a timely and accurate diagnosis. In this study, we evaluated the diagnostic performance of FDG-PET/CT in patients with suspected PTLD and examined if lactate dehydrogenase (LDH) levels, Epstein-Barr virus (EBV) load, or timing of FDG-PET/CT relate to detection performance of FDG-PET/CT. METHODS: This retrospective study included 91 consecutive patients with clinical suspicion of PTLD and a total of 97 FDG-PET/CT scans within an 8-year period. Pathology reports and a 2-year follow-up were used as the reference standard. Diagnostic performance of FDG-PET/CT for detection of PTLD as well as logistic regression analysis for factors expected to affect diagnostic yield were assessed. RESULTS: The diagnosis of PTLD was established in 34 patients (35%). Fifty-seven FDG-PET/CT scans (59%) were true negative, 29 (30%) were true positive, 6 (6%) false positive, and 5 (5%) false negative. Sensitivity of FDG-PET/CT for the detection of PTLD was 85%, specificity 90%, positive predictive value 83%, and negative predictive value 92%, with good inter-observer variability (k = 0.78). Of the parameters hypothesized to be associated with a true positive FDG-PET/CT result for the diagnosis of PTLD, only LDH was statistically significant (OR 1.03, p = 0.04). CONCLUSION: FDG-PET/CT has a good diagnostic performance in patients suspected of PTLD, with a good inter-observer agreement. Only LDH levels seemed to influence the detection performance of FDG-PET/CT. EBV-DNA load and timing of FDG-PET/CT after transplantation did not affect FDG-PET/CT diagnostic yield.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Montes de Jesus FM, Kwee TC, Kahle XU, et al. Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield. Eur J Nucl Med Mol Imaging. 2019. PMID: 31444510. doi:10.1007/s00259-019-04481-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。